PMV Consumer Acquisition (PMVCW) 10-Q/A 15 Feb 22 2020 Q3 Quarterly report (amended) Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Sep. 30, 2020	Feb. 15, 2022
Document Information Line Items
Entity Registrant Name	PMV Consumer Acquisition Corp.
Document Type	10-Q/A
Current Fiscal Year End Date	--12-31
Amendment Flag	true
Amendment Description	References throughout this Amendment No. 1 to the Quarterly Report on Form 10-Q to “we”, “us”, “PMV”, the “Company” or “our company” are to PMV Consumer Acquisition Corp., unless the context otherwise indicates.This Amendment No. 1 (“Amendment No. 1”) to the Quarterly Report on Form 10-Q/A amends the Quarterly Report on Form 10-Q of PMV Consumer Acquisition Corp. as of and for the period ended September 30, 2020 (the “Relevant Period”), as filed with the Securities and Exchange Commission (“SEC”) on November 5, 2020 (the “Original Filing”). The restatement for the period ended September 30, 2020 is a result of the following errors:●The Company’s accounting for a portion of its Class A common stock subject to possible redemption as temporary equity rather than permanent equity; and●The Company’s accounting for its outstanding warrants issued in connection with its initial public offering in September 2020 as components of equity instead of as derivative liabilities.Accounting for Class A common stock subject to possible redemption:On September 24, 2020, the Company consummated its Initial Public Offering (“IPO”) of 17,500,000 units (the “Units”, and with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at an offering price of $10.00 per Unit, generating gross proceeds of $175.00 million. Simultaneously with the closing of the IPO, the Company consummated the private placement (“Private Placement”) of 6,150,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant with PMV Consumer Acquisition Holding Company, LLC (the “Sponsor”), generating gross proceeds of approximately $6.15 million.On October 28, 2021, the Company filed its Form 10-Q for the quarterly period ending September 30, 2021 (the “Q3 2021 Form 10-Q”), which included Note 2, Revision of Previously Issued Financial Statements, (“Note 2”) that describes a revision to the Company’s classification of its Public Shares issued in the Company’s IPO on September 24, 2020. Upon its IPO, the Company classified a portion of the Public Shares as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that the Company will consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001. As described in Note 2, the Company’s management re-evaluated its previously held view that classification of $5,000,001 in permanent equity was appropriate, and determined that all of the Public Shares should be reclassified to temporary equity on its balance sheet. This resulted in an adjustment to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.In connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its earnings per share to allocate net income (loss) pro-rata to all Public Shares and Class B convertible common stock.However, the Company determined at the time that this error was not qualitatively material to the Company’s previously issued financial statements and did not restate its financial statements. Instead, the Company revised its previously filed financial statements in Note 2 to its Q3 2021 Form 10-Q. Subsequently, as described below, management determined that the prior classification of a portion of Class A common stock as temporary equity was a material error. Although the qualitative factors that management assessed tended to support a conclusion that the misstatements were not material, these factors were not strong enough to overcome the significant quantitative errors in the financial statements. The qualitative and quantitative factors support a conclusion that the misstatements are material on a quantitative basis. As such, upon further consideration of the change, the Company determined the change in classification of the Class A common stock and change to its presentation of earnings per share is material quantitatively and it should restate its previously issued financial statements.Therefore, on December 15, 2021, the Company’s management and the audit committee of the Company’s board of directors (the “Audit Committee”) concluded that the Company’s previously issued (i) audited financial statements as of December 31, 2020, as previously restated in the Company’s Annual Report on Form 10-K/A No. 1, filed with the SEC on May 14, 2021 (“2020 Form 10-K/A No. 1”, or the “Amendment”), (ii) unaudited interim financial statements included in the Form 10-Q for the quarterly period ended September 30, 2020, as previously revised in the 2020 Form 10-K/A No. 1; (iii) unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, filed with the SEC on May 17, 2021; (iv) unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on July 30, 2021, and (v) Note 2 to the unaudited interim financial statements and Item 4 of Part 1 included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the SEC on October 28, 2021 (collectively, the “Affected Periods”), should be restated to report all Class A common stock as temporary equity (and other related changes) and should no longer be relied upon.As such, the Company will restate the audited financial statements included in the 2020 Form 10-K/A No. 1 in an amendment to its Annual Report on Form 10-K/A as of and for the period ended December 31, 2020 (“2020 Form 10-K/A No. 2”). The Company will restate the unaudited interim financial statements for the quarterly periods ended September 30, 2020 (“Q3 2020 Form 10-Q/A”), March 31, 2021 (“Q1 2021 Form 10-Q/A”), June 30, 2021 (“Q2 2021 Form 10-Q/A”) and footnote 2 to the unaudited interim financial statements and Item 4 of Part 1 included in the Q3 2021 Form 10-Q (“Q3 2021 Form 10-Q/A”) in a separate Quarterly Report on Form 10-Q/A for each period.The Company determined that none of the above changes will have any impact on its cash position and cash held in the trust account established in connection with the IPO.After re-evaluation, the Company’s management has concluded that in light of the errors described above, a material weakness existed in the Company’s internal control over financial reporting during the Affected Periods and that the Company’s disclosure controls and procedures were not effective. The Company’s remediation plan with respect to such material weakness is described in more detail in Item 4 of Part I of the Q3 2021 Form 10-Q/A.Accounting for warrants:On May 14, 2021, the Company filed the Amendment to amend its Annual Report on Form 10-K for the period ended December 31, 2020, originally filed with the Securities and Exchange Commission, or the SEC, on March 11, 2021, to restate (i) its financial statements as of and for the period ended December 31, 2020 and (ii) its financial statements as of September 30, 2020. The Company did not amend its previously filed Quarterly Report on Form 10-Q for September 30, 2020, the restatement and its related impact were described in footnote 2 of the notes to the financial statements included in the Amendment. The financial information that was previously filed or otherwise reported for the period ended September 30, 2020 was superseded by the information in the Amendment.The Amendment details that the restatement resulted from the Company’s prior accounting for its outstanding warrants issued in connection with its initial public offering in September 2020 as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant.As described above, on December 15, 2021, the Company’s management and the audit committee of the Company’s board of directors (the “Audit Committee”) concluded that the Company’s previously issued unaudited interim financial statements included in the Form 10-Q for the quarterly period ended September 30, 2020, as previously restated in the 2020 Form 10-K/A No. 1, should be restated and reissued to correct the accounting for Class A common stock subject to possible redemption as temporary equity. In connection with the restatement and reissuance of the 2020 Form 10-Q/A for that matter, the Company’s management and audit committee concluded that the 2020 Form 10-Q/A should be further restated to reflect the warrant accounting restatement (and related changes) described in brief in the paragraph above and in detail in the Amendment. The 2020 Form 10-Q/A will reflect the outstanding warrants as derivative liabilities rather than as components of equity, conforming to the presentation in footnote 2 of the 2020 Form 10-K/A No. 1.Items Amended:The following items are amended in this Amendment: (i) Part I, Item 1. Financial Statements; (ii) Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations; (iii) Part I, Item 4. Controls and Procedures; (iv) Part II, Item 1a. Risk Factors; and (v) Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. Additionally, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, the Company is including with this Amendment currently dated certifications from its principal executive and principal financial officer. These certifications are filed or furnished, as applicable, as Exhibits 31.1 and 32.1.Except as described above, this Amendment does not amend, update or change any other disclosures in the Original Filing. In addition, the information contained in this amendment does not reflect events occurring after the filing of the Original Filing and does not modify or update the disclosures therein, except as specifically identified above. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing and the Company’s other filings with the SEC. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Original Filing. Unless the context otherwise requires, references to “warrants” in this Amendment No. 1 refers to both PMV’s public warrants and PMV’s Private Placement Warrants (as defined herein).
Entity Central Index Key	0001807765
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Transition Report	false
Entity File Number	001-39534
Entity Incorporation, State or Country Code	DE
Entity Interactive Data Current	No
Class A Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		17,500,000
Class B Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		4,375,000

Condensed Balance Sheet (Unaudi

Condensed Balance Sheet (Unaudited)	Sep. 30, 2020USD ($)
Current assets:
Cash and cash equivalents	$ 2,834,970
Prepaid expenses	37,429
Total current assets	2,872,399
Cash and marketable securities held in Trust Account	175,002,426
TOTAL ASSETS	177,874,825
Current liabilities:
Accounts payable and accrued expenses	2,525
Accrued offering costs	383,080
Franchise taxes payable	108,000
Promissory note – related party	150,000
Total current liabilities	643,605
Deferred underwriting fee payable	6,125,000
Derivative warrant liabilities	14,864,500
Total Liabilities	21,633,105
Commitments and Contingencies
Class A common stock subject to possible redemption, 17,500,000 shares at redemption value of $10.00 per share	175,000,000
Stockholders’ Equity (Deficit)
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Class A common stock, $0.0001 par value; 75,000,000 shares authorized
Class B convertible common stock, $0.0001 par value; 10,000,000 shares authorized; 4,375,000 shares issued and outstanding	503	[1]
Additional paid-in capital
Accumulated deficit	(18,758,783)
Total Stockholders’ Equity (Deficit)	(18,758,280)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 177,874,825
[1]	Includes an aggregate of up to 656,250 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B common stock. All shares and associated amounts have been retroactively restated to reflect the forward stock split (see Note 6).

Condensed Balance Sheet (Unau_2

Condensed Balance Sheet (Unaudited) (Parentheticals)	6 Months Ended
	Sep. 30, 2020$ / sharesshares
Common stock subject to possible redemption per share (in Dollars per share) | $ / shares	$ 10
Common stock subject to possible redemption	17,500,000
Preferred stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Common Stock
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares authorized	75,000,000
Class B convertible common stock
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares authorized	10,000,000
Common stock, shares issued	5,031,250
Common stock, shares outstanding	5,031,250

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)		3 Months Ended	6 Months Ended
		Sep. 30, 2020	Sep. 30, 2020
General and administrative expenses		$ 5,291	$ 5,816
Franchise tax expense		108,000	108,000
Loss from operations		(113,291)	(113,816)
Other income (expense):
Interest earned on marketable securities held in Trust Account		2,426	2,426
Offering costs associated with warrants recorded as liabilities		(379,848)	(379,848)
Other income (expense)		(377,422)	(377,422)
Loss before provision for income taxes		(490,713)	(491,238)
Provision for income taxes
Net loss		$ (490,713)	$ (491,238)
Class A Common Stock
Other income (expense):
Weighted average shares outstanding (in Shares)		1,346,154	621,827
Basic and diluted net loss per share (in Dollars per share)		$ (0.09)	$ (0.10)
Class B Convertible Common Stock
Other income (expense):
Weighted average shares outstanding (in Shares)	[1]	4,375,000	4,375,000
Basic and diluted net loss per share (in Dollars per share)		$ (0.09)	$ (0.10)
[1]	Excludes an aggregate of up to 656,250 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (See Note 6). On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B common stock. All shares and associated amounts have been retroactively restated to reflect the forward stock split (see Note 6).

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)	Class ACommon Stock	Class B ConvertibleCommon Stock		Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Mar. 17, 2020
Balance (in Shares) at Mar. 17, 2020			[1]
Issuance of Founder Shares to Sponsor		$ 503		24,497		25,000
Issuance of Founder Shares to Sponsor (in Shares)		5,031,250	[1]
Net loss					(525)	(525)
Balance at Mar. 31, 2020		$ 503		24,497	(525)	24,475
Balance (in Shares) at Mar. 31, 2020		5,031,250	[1]
Balance at Mar. 17, 2020
Balance (in Shares) at Mar. 17, 2020			[1]
Balance at Sep. 30, 2020		$ 503			(18,758,783)	(18,758,280)
Balance (in Shares) at Sep. 30, 2020		5,031,250	[1]
Balance at Mar. 31, 2020		$ 503		24,497	(525)	24,475
Balance (in Shares) at Mar. 31, 2020		5,031,250	[1]
Net loss
Balance at Jun. 30, 2020		$ 503		24,497	(525)	24,475
Balance (in Shares) at Jun. 30, 2020		5,031,250	[1]
Accretion for Class A common stock to redemption amount				(24,497)	(18,267,545)	(18,292,042)
Net loss					(490,713)	(490,713)
Balance at Sep. 30, 2020		$ 503			$ (18,758,783)	$ (18,758,280)
Balance (in Shares) at Sep. 30, 2020		5,031,250	[1]
[1]	Includes an aggregate of up to 656,250 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (See Note 6). On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B common stock. All shares and associated amounts have been retroactively restated to reflect the forward stock split (see Note 6)

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows (Unaudited)	6 Months Ended
	Sep. 30, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (491,238)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(2,426)
Offering costs associated with warrants recorded as liabilities	379,848
Changes in operating assets and liabilities:
Prepaid expenses	(37,429)
Accrued expenses	110,525
Net cash used in operating activities	(40,720)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(175,000,000)
Net cash used in Investing Activities	(175,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	171,500,000
Proceeds from sale of Founder Shares	25,000
Proceeds from sale of Private Warrants	6,150,000
Proceeds from promissory note – related party	150,000
Proceeds from underwriter’s rebate	175,000
Payment of offering costs	(124,310)
Net cash provided by financing activities	177,875,690
Net Change in Cash	2,834,970
Cash and cash equivalents – Beginning of period
Cash and cash equivalents – End of period	2,834,970
Non-cash investing and financing activities:
Offering costs included in accrued offering costs	383,080
Deferred underwriting fee payable	$ 6,125,000

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1—DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS PMV Consumer Acquisition Corp. (the “Company”) was incorporated in Delaware on March 18, 2020. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on companies in the consumer industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2020, the Company had not commenced any operations. All activity for the period from March 18, 2020 (inception) through September 30, 2020, relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on September 21, 2020. On September 24, 2020, the Company consummated the Initial Public Offering of 17,500,000 units (the “Units” and, with respect to the shares of common stock included in the Units Sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $175,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,150,000 warrants (the “Private Warrants”) at a price of $1.00 per Private Warrant in a private placement to PMV Consumer Acquisition Holding Company, LLC (the “Sponsor”), generating gross proceeds of $6,150,000, which is described in Note 4. Offering costs amounted to $9,957,390, consisting of $3,500,000 of underwriting fees, $6,125,000 of deferred underwriting fees and $507,390 of other offering costs, of which $175,000 was offset with a credit paid by the Underwriter. In addition, at September 30, 2020, $2,834,970 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes. Following the closing of the Initial Public Offering on September 24, 2020, an amount of $175,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”) located in the United States, which will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-end investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account and deferred underwriting commissions) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants, including the Private Warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, solely if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation, as amended (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote the Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction, or do not vote at all. Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group”, will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination or an amendment to the Company’s Certificate of Incorporation described below, (b) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to consummate a Business Combination, and (c) not to propose an amendment to the Company’s Certificate of Incorporation to modify a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the required time period, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until September 24, 2022, (or such later date as may be approved by the stockholders in an amendment to the Certificate of Incorporation) to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income tax obligations and net of up to $50,000 of interest available to be used for liquidation expenses, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, except as to any claims by a third party who executed an agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	6 Months Ended
	Sep. 30, 2020
Restatement Of Previously Issued Financial Statements [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Accounting for Class A common stock subject to possible redemption: The Company concluded it should restate its previously issued financial statements to classify all Class A common stock in temporary equity. In accordance with ASC 480-10-S99, redemption provisions not solely within the control of the Company require shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Class A common stock in permanent equity, or total stockholders’ equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that the Company will not redeem its Class A common stock in an amount that would cause its net tangible assets to be less than $5,000,001. Also, in connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares share pro rata in the income and losses of the Company. As a result, the Company restated its previously filed financial statements to present all redeemable Class A common stock as temporary equity and to recognize a re-measurement adjustment from the initial book value to redemption value at the time of its Initial Public Offering. Accounting for warrants: In connection with the restatement and reissuance of the previously issued financial statements for the Class A common stock classification error described above, the Company concluded that its previously issued financial statements should be restated to reflect the warrant accounting restatement (and related changes) described in footnote 2 of the Company’s Annual Report on Form 10-K/A No. 1, filed with the SEC on May 14, 2021, which superseded the previously issued Form 10-Q for the period ended September 30, 2020. The Company previously accounted for its outstanding Public Warrants and Private Placement Warrants as components of equity instead of as derivative liabilities. Upon review of the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (SPACs)” promulgated by the SEC on April 12, 2021, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company should reclassify the warrants as derivative liabilities, with changes in fair value recognized in earnings each period. Impact of the Restatements The impact of the restatements on the balance sheet, statements of operations and statement of cash flows for the Relevant Period is presented below. The restatements had no impact on net cash flows from operating, investing or financing activities. As of September 30, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 177,874,825 $ - $ 177,874,825 Liabilities and stockholders’ equity Total current liabilities $ 643,605 $ - $ 643,605 Deferred underwriting commissions 6,125,000 - 6,125,000 Derivative warrant liabilities - 14,864,500 14,864,500 Total liabilities 6,768,605 14,864,500 21,633,105 Class A common stock subject to possible redemption, 166,106,210 8,893,790 175,000,000 Stockholders’ equity (deficit) Preferred stock- $0.0001 par value - - - Class A common stock - $0.0001 par value 89 (89 ) - Class B common stock - $0.0001 par value 503 - 503 Additional paid-in-capital 5,110,808 (5,110,808 ) - Accumulated deficit (111,390 ) (18,647,393 ) (18,758,783 ) Total stockholders’ equity (deficit) 5,000,010 (23,758,290 ) (18,758,280 ) Total liabilities and stockholders’ equity (deficit) $ 177,874,825 $ - $ 177,874,825 For the Three Months Ended As Previously Reported Restatement Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (113,291 ) $ - $ (113,291 ) Other (expense) income: Interest earned on investments held in Trust Account 2,426 - 2,426 Change in fair value on derivative warrant liabilities - - - Offering costs associated with warrants recorded as liabilities - (379,848 ) (379,848 ) Total other (expense) income 2,426 (379,848 ) (377,422 ) Net loss $ (110,865 ) $ (379,848 ) $ (490,713 ) Weighted-average shares outstanding, of Class A common stock 17,500,000 (16,153,846 ) 1,346,154 Basic and Diluted net loss per share, Class A common stock $ 0.00 $ (0.09 ) $ (0.09 ) Weighted-average shares outstanding, of Class B convertible common stock 4,375,000 - 4,375,000 Basic and Diluted net loss per share, Class B convertible common stock $ (0.03 ) $ (0.06 ) $ (0.09 ) Impact of the Restatements (Cont.) For the period from March 18, 2020 (inception) through September 30, 2020 As Previously Reported Restatement Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (113,816 ) $ - $ (113,816 ) Other (expense) income: Interest earned on investments held in Trust Account 2,426 - 2,426 Change in fair value on derivative warrant liabilities - - - Offering costs associated with warrants recorded as liabilities - (379,848 ) (379,848 ) Total other (expense) income 2,426 (379,848 ) (377,422 ) Net loss $ (111,390 ) $ (379,848 ) $ (491,238 ) Weighted-average shares outstanding, of Class A common stock 17,500,000 (16,878,173 ) 621,827 Basic and Diluted net loss per share, Class A common stock $ 0.00 $ (0.10 ) $ (0.10 ) Weighted-average shares outstanding, of Class B convertible common stock 4,375,000 - 4,375,000 Basic and Diluted net loss per share, Class B convertible common stock $ (0.03 ) $ (0.07 ) $ (0.10 ) For the period from March 18, 2020 As Previously Reported Restatement Adjustment As Restated Unaudited Condensed Statement of Cash Flows Net loss $ (111,390 ) $ (379,848 ) $ (491,238 ) Adjustment to reconcile net loss to net cash used in operating activities 70,670 379,848 450,518 Net cash used in operating activities (40,720 ) - (40,720 ) Net cash used in investing activities (175,000,000 ) - (175,000,000 ) Net cash provided by financing activities 177,875,690 - 177,875,690 Non-Cash Investing and Financing Activities Initial classification of Class A common stock subject to possible redemption $ 166,224,660 $ (166,224,660 ) $ - Going Concern In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete a Business Combination by September 24, 2022, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 24, 2022. The Company intends to complete a Business Combination before the mandatory liquidation date.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus for our Initial Public Offering filed with the SEC on September 21, 2020. The interim results for the Period from March 18, 2020 (inception) through September 30, 2020, and the three months ended September 30, 2020, along with the Company’s recently filed Form 8-K, filed with the SEC on September 30, 2020, are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standards at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2020. Marketable securities held in Trust Account At September 30, 2020, the assets held in the Trust Account were held in U.S. Treasury Bills. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2020, 17,500,000 shares of Class A common stock subject to possible redemption, are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheet. The Company has classified all of the shares of Class A common stock as temporary equity. Immediately upon the closing of the Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. The Class A common stock subject to possible redemption reflected on the balance sheet as of September 30, 2020, are reconciled in the following table: Gross proceeds $ 175,000,000 Less: Proceeds allocated to public warrants (8,837,500 ) Class A shares offering costs (9,454,542 ) Plus: Accretion of carrying value to redemption value 18,292,042 Class A common stock subject to possible redemption $ 175,000,000 Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs were allocated on a relative fair value basis between temporary equity, stockholders’ equity (deficit) and expense. The portion of offering costs allocated to the public warrants has been charged to expense. The portion of the offering costs allocated to the public shares has been charged to temporary equity. On September 24, 2020, offering costs amounting to $9,957,390 (consisting of $3,500,000 of underwriting fees, $6,125,000 of deferred underwriting fees and $507,390 of other offering costs, net of a $175,000 credit paid by the Underwriter), was allocated as follows, $502,848 in offering costs was charged to expense and $9,454,542 was charged to temporary equity. Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the warrants was estimated using a Monte Carlo simulation approach (see Note 9). Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements’ carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2020, the Company had a deferred tax asset of approximately $23,000, which had a full valuation allowance recorded against it of approximately $23,000. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOLs”) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. Net Income (Loss) per Common Share Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period. The Company has not considered the effect of warrants to purchase 14,900,000 shares of Class A common stock that were sold in the Initial Public Offering and the private placement in the calculation of diluted income (loss) per share, since the average market price of the Company’s Class A common stock for the three months ended September 30, 2020 and the period from March 18, 2020 (Inception) to September 30, 2020, was below the Warrants’ $11.50 exercise price and the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted income (loss) per common share is the same as basic income (loss) per common share for the period presented. The Company has two classes of shares, which are referred to as Class A common stock (the “Common Stock”) and Class B convertible common stock (the “Founder Shares”). Earnings and losses are shared pro rata between the two classes of shares as long as a business combination is consummated. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Sep. 30, 2020
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 4—INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 17,500,000 Units at a price of $10.00 per Unit. Each consists of one share of Class A common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

Private Placement

Private Placement	6 Months Ended
	Sep. 30, 2020
Private Placement [Abstract]
PRIVATE PLACEMENT	NOTE 5—PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,150,000 Private Warrants at a price of $1.00 per Private Warrant, for an aggregate purchase price of $6,150,000. Each Private Warrant is exercisable to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 7). The proceeds from the Private Warrants will be added to the proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Warrants will expire worthless.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6—RELATED PARTY TRANSACTIONS Founder Shares On March 20, 2020, the Sponsor purchased 3,593,750 shares of Class B common stock (the “Founder Shares”) for an aggregate price of $25,000, or approximately $0.007 per share. As used herein, unless the context otherwise requires, “Founder Shares” shall be deemed to include the shares of Class A common stock issuable upon conversion thereof. On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B common stock. Resulting in an aggregate of 5,031,250 Founder Shares being outstanding, of which an aggregate of up to 656,250 shares were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). As of September 30, 2020 the over-allotment option has not been exercised, consequently 656,250 Founder Shares may be forfeited. As of September 30, 2020, the issued and outstanding shares of Class B convertible common stock is 5,031,250 shares. The Founder Shares are identical to the Class A common stock included in the Units sold in the Initial Public Offering except that the Founder Shares automatically convert into shares of Class A common stock at the time of the Company’s Initial Business Combination, are subject to certain transfer restrictions as described in more detail below, and prior to a Business Combination have the exclusive right to elect, replace and remove the directors of the Company. Holders of Founder Shares may also elect to convert their shares of Class B convertible common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares in connection with the completion of a Business Combination or an amendment to the Company’s Certificate of Incorporation described below, (b) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to consummate a Business Combination, and (c) not to propose an amendment to the Company’s Certificate of Incorporation to modify a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the required time period, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares following the Initial Public Offering until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination. The Sponsor and the Company’s officers and directors have also agreed to vote any Founder Shares held by them and any public shares purchased after Initial Public Offering (including in open market and privately negotiated transactions) in favor of a Business Combination. Promissory Note—Related Party On June 16, 2020, the Sponsor agreed to loan the Company up to an aggregate of $150,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan is non-interest bearing and payable on the earlier of (i) June 16, 2021, (ii) the completion of the Initial Public Offering or (iii) the date on which the Company determines not to proceed with the Initial Public Offering. At September 30, 2020, the Company had $150,000 outstanding under the Note. Subsequent to the period ended September 30, 2020, the Note had been repaid in full on October 13, 2020. Administrative Support Agreement The Company entered into an agreement whereby, commencing September 24, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the period from March 18, 2020 (inception) through September 30, 2020, the Company incurred $2,000 in fees for these services, of which such amount is included in accounts payable and accrued expenses in the accompanying condensed balance sheet. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, the Company’s officers or directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Warrants. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2020, there were no Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7—COMMITMENTS AND CONTINGENCIES Registration Rights Pursuant to a registration rights agreement entered into on September 24, 2020, the holders of the Founder Shares, Private Warrants (and their underlying securities) and any warrants that may be issued upon conversion of working capital loans (“Working Capital Warrants”), if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A common stock). These holders will be entitled to certain demand and “piggyback” registration rights. The holders of Founder Shares and Private Placement Warrants will not be able to sell these securities until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, $6,125,000. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination within the Combination Period, subject to the terms of the underwriting agreement. Risks and Uncertainties Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	6 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	NOTE 8—STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock Common Stock If the Company enters into an initial Business Combination, it may (depending on the terms of such an initial Business Combination) be required to increase the number of shares of Class A common stock which the Company is authorized to issue at the same time as the Company’s stockholders vote on the Business Combination, to the extent the Company seeks stockholder approval in connection with the Business Combination. Holders of the Company’s common stock are entitled to one vote for each share of common stock. At September 30, 2020, there were 17,500,000 shares of Class A common stock issued and outstanding, including 17,500,000 shares of Class A common stock subject to possible redemption which have been reflected as temporary equity on the condensed balance sheet. At September 30, 2020, there were 5,031,250 shares of Class B convertible common stock issued and outstanding, of which 656,250 shares were subject to forfeiture if the over-allotment option (previously discussed in Note 6) is not exercised in full or in part by the underwriters. Warrants Under the terms of the warrant agreement, the Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file a registration statement under the Securities Act covering such shares and maintain a current prospectus relating to the shares of Class A common stock issuable upon exercise of the warrants until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective within 60 days following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Once the warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption; ● if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Warrants (Cont.) – The Private Warrants will be identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchaser or its permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to our sponsor, initial stockholders or their affiliates, without taking into account any founders’ shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated an initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which we issue the additional shares of common stock or equity-linked securities, and the $18.00 per share redemption trigger price of the warrants will be adjusted (to the nearest cent) to be equal to 180% of the greater of (i) the Market Value or (ii) the price at which we issue the additional shares of common stock or equity-linked securities.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 9—FAIR VALUE MEASUREMENTS The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC 320 “Investments – Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheet and adjusted for the amortization or accretion of premiums or discounts. At September 30, 2020, assets held in the Trust Account were comprised of $579 in cash and $175,001,847 in U.S. Treasury Bills, which are held at amortized cost. The gross holding losses and fair value of held-to-maturity securities at September 30, 2020 are as follow: Level 1: Held-To-Maturity Amortized Cost Gross Holding Fair Value September 30, 2020 U.S. Treasury Securities (Mature on 03/25/2021) $ 175,001,847 $ (17,628 ) $ 174,984,219 The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following tables present information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2020, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. Description September 30, Quoted Prices Significant Significant Assets: Cash and marketable securities held in Trust Account $ 175,002,426 $ 175,002,426 $ — $ — Liabilities: Warrant Liability – Public Warrants $ 8,837,500 $ — $ — $ 8,837,500 Warrant Liability – Private Placement Warrants $ 6,027,000 $ — $ — $ 6,027,000 Level 3 financial liabilities consist of the Public Warrant and Private Placement Warrant liability for which there is little or no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company utilizes a Monte Carlo simulation model to value the warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. However, inherent uncertainties are involved. If factors or assumptions change, the estimated fair values could be materially different. The aforementioned warrant liabilities are not subject to qualified hedge accounting. There were no transfers between levels within the fair value hierarchy during the period ended September 30, 2020. The following table provides quantitative information regarding Level 3 fair value measurements: As of Stock price $ 9.50 Strike price $ 11.50 Term (in years) 5.0 Volatility 25.00 % Risk-free rate 0.41 % Dividend yield 0.00 % Probability of completing a Business Combination 70.00 % The following table presents the changes in the fair value of warrant liabilities: Private Public Total Fair value as of March 18, 2020 (inception) $ — $ — $ — Initial measurement on September 30, 2020 (1) 6,027,000 8,837,500 14,864,500 Change in fair value recognized in earnings — — — Fair value as of September 30, 2020 $ 6,027,000 $ 8,837,500 $ 14,864,500 (1) There was no measurable difference in fair value between the date of our Initial Public Offering on September 24, 2020, and September 30, 2020.

Subsequent Events

Subsequent Events	6 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10—SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements, other than the restatements discussed in Note 2.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus for our Initial Public Offering filed with the SEC on September 21, 2020. The interim results for the Period from March 18, 2020 (inception) through September 30, 2020, and the three months ended September 30, 2020, along with the Company’s recently filed Form 8-K, filed with the SEC on September 30, 2020, are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standards at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2020.
Marketable securities held in Trust Account	Marketable securities held in Trust Account At September 30, 2020, the assets held in the Trust Account were held in U.S. Treasury Bills.
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2020, 17,500,000 shares of Class A common stock subject to possible redemption, are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheet. The Company has classified all of the shares of Class A common stock as temporary equity. Immediately upon the closing of the Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. The Class A common stock subject to possible redemption reflected on the balance sheet as of September 30, 2020, are reconciled in the following table: Gross proceeds $ 175,000,000 Less: Proceeds allocated to public warrants (8,837,500 ) Class A shares offering costs (9,454,542 ) Plus: Accretion of carrying value to redemption value 18,292,042 Class A common stock subject to possible redemption $ 175,000,000
Offering Costs	Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs were allocated on a relative fair value basis between temporary equity, stockholders’ equity (deficit) and expense. The portion of offering costs allocated to the public warrants has been charged to expense. The portion of the offering costs allocated to the public shares has been charged to temporary equity. On September 24, 2020, offering costs amounting to $9,957,390 (consisting of $3,500,000 of underwriting fees, $6,125,000 of deferred underwriting fees and $507,390 of other offering costs, net of a $175,000 credit paid by the Underwriter), was allocated as follows, $502,848 in offering costs was charged to expense and $9,454,542 was charged to temporary equity.
Warrant Liability	Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the warrants was estimated using a Monte Carlo simulation approach (see Note 9).
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements’ carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2020, the Company had a deferred tax asset of approximately $23,000, which had a full valuation allowance recorded against it of approximately $23,000. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOLs”) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions.
Net Income (Loss) per Common Share	Net Income (Loss) per Common Share Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period. The Company has not considered the effect of warrants to purchase 14,900,000 shares of Class A common stock that were sold in the Initial Public Offering and the private placement in the calculation of diluted income (loss) per share, since the average market price of the Company’s Class A common stock for the three months ended September 30, 2020 and the period from March 18, 2020 (Inception) to September 30, 2020, was below the Warrants’ $11.50 exercise price and the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted income (loss) per common share is the same as basic income (loss) per common share for the period presented. The Company has two classes of shares, which are referred to as Class A common stock (the “Common Stock”) and Class B convertible common stock (the “Founder Shares”). Earnings and losses are shared pro rata between the two classes of shares as long as a business combination is consummated. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	6 Months Ended
	Sep. 30, 2020
Restatement Of Previously Issued Financial Statements [Abstract]
Schedule of financial statement	As of September 30, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 177,874,825 $ - $ 177,874,825 Liabilities and stockholders’ equity Total current liabilities $ 643,605 $ - $ 643,605 Deferred underwriting commissions 6,125,000 - 6,125,000 Derivative warrant liabilities - 14,864,500 14,864,500 Total liabilities 6,768,605 14,864,500 21,633,105 Class A common stock subject to possible redemption, 166,106,210 8,893,790 175,000,000 Stockholders’ equity (deficit) Preferred stock- $0.0001 par value - - - Class A common stock - $0.0001 par value 89 (89 ) - Class B common stock - $0.0001 par value 503 - 503 Additional paid-in-capital 5,110,808 (5,110,808 ) - Accumulated deficit (111,390 ) (18,647,393 ) (18,758,783 ) Total stockholders’ equity (deficit) 5,000,010 (23,758,290 ) (18,758,280 ) Total liabilities and stockholders’ equity (deficit) $ 177,874,825 $ - $ 177,874,825 For the Three Months Ended As Previously Reported Restatement Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (113,291 ) $ - $ (113,291 ) Other (expense) income: Interest earned on investments held in Trust Account 2,426 - 2,426 Change in fair value on derivative warrant liabilities - - - Offering costs associated with warrants recorded as liabilities - (379,848 ) (379,848 ) Total other (expense) income 2,426 (379,848 ) (377,422 ) Net loss $ (110,865 ) $ (379,848 ) $ (490,713 ) Weighted-average shares outstanding, of Class A common stock 17,500,000 (16,153,846 ) 1,346,154 Basic and Diluted net loss per share, Class A common stock $ 0.00 $ (0.09 ) $ (0.09 ) Weighted-average shares outstanding, of Class B convertible common stock 4,375,000 - 4,375,000 Basic and Diluted net loss per share, Class B convertible common stock $ (0.03 ) $ (0.06 ) $ (0.09 ) For the period from March 18, 2020 (inception) through September 30, 2020 As Previously Reported Restatement Adjustment As Restated Unaudited Condensed Statement of Operations Loss from operations $ (113,816 ) $ - $ (113,816 ) Other (expense) income: Interest earned on investments held in Trust Account 2,426 - 2,426 Change in fair value on derivative warrant liabilities - - - Offering costs associated with warrants recorded as liabilities - (379,848 ) (379,848 ) Total other (expense) income 2,426 (379,848 ) (377,422 ) Net loss $ (111,390 ) $ (379,848 ) $ (491,238 ) Weighted-average shares outstanding, of Class A common stock 17,500,000 (16,878,173 ) 621,827 Basic and Diluted net loss per share, Class A common stock $ 0.00 $ (0.10 ) $ (0.10 ) Weighted-average shares outstanding, of Class B convertible common stock 4,375,000 - 4,375,000 Basic and Diluted net loss per share, Class B convertible common stock $ (0.03 ) $ (0.07 ) $ (0.10 ) For the period from March 18, 2020 As Previously Reported Restatement Adjustment As Restated Unaudited Condensed Statement of Cash Flows Net loss $ (111,390 ) $ (379,848 ) $ (491,238 ) Adjustment to reconcile net loss to net cash used in operating activities 70,670 379,848 450,518 Net cash used in operating activities (40,720 ) - (40,720 ) Net cash used in investing activities (175,000,000 ) - (175,000,000 ) Net cash provided by financing activities 177,875,690 - 177,875,690 Non-Cash Investing and Financing Activities Initial classification of Class A common stock subject to possible redemption $ 166,224,660 $ (166,224,660 ) $ -

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Schedule of Class A ordinary shares subject to possible redemption reflected on the balance sheet	Gross proceeds $ 175,000,000 Less: Proceeds allocated to public warrants (8,837,500 ) Class A shares offering costs (9,454,542 ) Plus: Accretion of carrying value to redemption value 18,292,042 Class A common stock subject to possible redemption $ 175,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Schedule of fair value of held-to-maturity securities	Level 1: Held-To-Maturity Amortized Cost Gross Holding Fair Value September 30, 2020 U.S. Treasury Securities (Mature on 03/25/2021) $ 175,001,847 $ (17,628 ) $ 174,984,219
Schedule of assets that are measured at fair value on a recurring basis	Description September 30, Quoted Prices Significant Significant Assets: Cash and marketable securities held in Trust Account $ 175,002,426 $ 175,002,426 $ — $ — Liabilities: Warrant Liability – Public Warrants $ 8,837,500 $ — $ — $ 8,837,500 Warrant Liability – Private Placement Warrants $ 6,027,000 $ — $ — $ 6,027,000
Schedule of quantitative information regarding level 3 fair value measurements	As of Stock price $ 9.50 Strike price $ 11.50 Term (in years) 5.0 Volatility 25.00 % Risk-free rate 0.41 % Dividend yield 0.00 % Probability of completing a Business Combination 70.00 %
Schedule of changes in the fair value of warrant liabilities	Private Public Total Fair value as of March 18, 2020 (inception) $ — $ — $ — Initial measurement on September 30, 2020 (1) 6,027,000 8,837,500 14,864,500 Change in fair value recognized in earnings — — — Fair value as of September 30, 2020 $ 6,027,000 $ 8,837,500 $ 14,864,500 (1) There was no measurable difference in fair value between the date of our Initial Public Offering on September 24, 2020, and September 30, 2020.

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)	1 Months Ended	6 Months Ended
	Sep. 24, 2020	Sep. 30, 2020
Description of Organization and Business Operations (Details) [Line Items]
Offering costs		$ 9,957,390
Underwriting fees		3,500,000
Deferred underwriting fees		6,125,000
Other offering costs		507,390
Offset credit paid by underwriter		175,000
Cash held outside of the trust account		$ 2,834,970
Initial public offering, description	Following the closing of the Initial Public Offering on September 24, 2020, an amount of $175,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”) located in the United States, which will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-end investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below.
Aggregate fair market value, percentage		80.00%
Percentage of outstanding voting securities		50.00%
Public share price per share (in Dollars per share)		$ 10
Net tangible assets		$ 5,000,001
Public share percentage		20.00%
Public shares redeem percentage		100.00%
Public price per share (in Dollars per share)		$ 10
Reduction per share (in Dollars per share)		10
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of shares (in Shares)	17,500,000
Sale of stock price per share (in Dollars per share)	$ 10
Gross proceeds	$ 175,000,000
Private Warrants [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of stock price per share (in Dollars per share)		$ 1
Sale of shares (in Shares)		6,150,000
Proceeds from sale of warrants		$ 6,150,000
Business Combination [Member]
Description of Organization and Business Operations (Details) [Line Items]
Business combination, description		(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income tax obligations and net of up to $50,000 of interest available to be used for liquidation expenses, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details)	Sep. 30, 2020USD ($)
Restatement Of Previously Issued Financial Statements [Abstract]
Net tangible assets	$ 5,000,001

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statement	3 Months Ended	6 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares	Sep. 30, 2020USD ($)$ / sharesshares
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Total assets	$ 177,874,825	$ 177,874,825
Liabilities and stockholders’ equity
Total current liabilities	643,605	643,605
Deferred underwriting commissions	6,125,000	6,125,000
Derivative warrant liabilities
Total liabilities	6,768,605	6,768,605
Class A common stock subject to possible redemption, at redemption value of $10.00 per share	166,106,210	166,106,210
Stockholders’ equity (deficit)
Preferred stock- $0.0001 par value
Additional paid-in-capital	5,110,808	5,110,808
Accumulated deficit	(111,390)	(111,390)
Total stockholders’ equity (deficit)	5,000,010	5,000,010
Total liabilities and stockholders’ equity (deficit)	177,874,825	177,874,825
Loss from operations	(113,291)	(113,816)
Other (expense) income:
Interest earned on investments held in Trust Account	2,426	2,426
Change in fair value on derivative warrant liabilities
Offering costs associated with warrants recorded as liabilities
Total other (expense) income	2,426	2,426
Net loss	(110,865)	(111,390)
Net loss		(111,390)
Adjustment to reconcile net loss to net cash used in operating activities		70,670
Net cash used in operating activities		(40,720)
Net cash used in investing activities		(175,000,000)
Net cash provided by financing activities		177,875,690
Non-Cash Investing and Financing Activities
Initial classification of Class A common stock subject to possible redemption		166,224,660
As Previously Reported [Member] | Class A Common Stock [Member]
Stockholders’ equity (deficit)
Class A common stock - $0.0001 par value	$ 89	$ 89
Other (expense) income:
Weighted-average shares outstanding, of Class A common stock (in Shares) | shares	17,500,000	17,500,000
Basic and Diluted net loss per share, Class A common stock (in Dollars per share) | $ / shares	$ 0	$ 0
As Previously Reported [Member] | Class B Common Stock [Member]
Stockholders’ equity (deficit)
Class B common stock - $0.0001 par value	$ 503	$ 503
As Previously Reported [Member] | Class B Convertible Common Stock [Member]
Other (expense) income:
Weighted-average shares outstanding, of Class B convertible common stock (in Shares) | shares	4,375,000	4,375,000
Basic and Diluted net loss per share, Class B convertible common stock (in Dollars per share) | $ / shares	$ (0.03)	$ (0.03)
Restatement Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Total assets
Liabilities and stockholders’ equity
Total current liabilities
Deferred underwriting commissions
Derivative warrant liabilities	14,864,500	14,864,500
Total liabilities	14,864,500	14,864,500
Class A common stock subject to possible redemption, at redemption value of $10.00 per share	8,893,790	8,893,790
Stockholders’ equity (deficit)
Preferred stock- $0.0001 par value
Additional paid-in-capital	(5,110,808)	(5,110,808)
Accumulated deficit	(18,647,393)	(18,647,393)
Total stockholders’ equity (deficit)	(23,758,290)	(23,758,290)
Total liabilities and stockholders’ equity (deficit)
Loss from operations
Other (expense) income:
Interest earned on investments held in Trust Account
Change in fair value on derivative warrant liabilities
Offering costs associated with warrants recorded as liabilities	(379,848)	(379,848)
Total other (expense) income	(379,848)	(379,848)
Net loss	(379,848)	(379,848)
Net loss		(379,848)
Adjustment to reconcile net loss to net cash used in operating activities		379,848
Net cash used in operating activities
Net cash used in investing activities
Net cash provided by financing activities
Non-Cash Investing and Financing Activities
Initial classification of Class A common stock subject to possible redemption		(166,224,660)
Restatement Adjustment [Member] | Class A Common Stock [Member]
Stockholders’ equity (deficit)
Class A common stock - $0.0001 par value	$ (89)	$ (89)
Other (expense) income:
Weighted-average shares outstanding, of Class A common stock (in Shares) | shares	(16,153,846)	(16,878,173)
Basic and Diluted net loss per share, Class A common stock (in Dollars per share) | $ / shares	$ (0.09)	$ (0.10)
Restatement Adjustment [Member] | Class B Convertible Common Stock [Member]
Other (expense) income:
Weighted-average shares outstanding, of Class B convertible common stock (in Shares) | shares
Basic and Diluted net loss per share, Class B convertible common stock (in Dollars per share) | $ / shares	$ (0.06)	$ (0.07)
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Total assets	$ 177,874,825	$ 177,874,825
Liabilities and stockholders’ equity
Total current liabilities	643,605	643,605
Deferred underwriting commissions	6,125,000	6,125,000
Derivative warrant liabilities	14,864,500	14,864,500
Total liabilities	21,633,105	21,633,105
Class A common stock subject to possible redemption, at redemption value of $10.00 per share	175,000,000	175,000,000
Stockholders’ equity (deficit)
Preferred stock- $0.0001 par value
Accumulated deficit	(18,758,783)	(18,758,783)
Total stockholders’ equity (deficit)	(18,758,280)	(18,758,280)
Total liabilities and stockholders’ equity (deficit)	177,874,825	177,874,825
Loss from operations	(113,291)	(113,816)
Other (expense) income:
Interest earned on investments held in Trust Account	2,426	2,426
Change in fair value on derivative warrant liabilities
Offering costs associated with warrants recorded as liabilities	(379,848)	(379,848)
Total other (expense) income	(377,422)	(377,422)
Net loss	(490,713)	(491,238)
Net loss		(491,238)
Adjustment to reconcile net loss to net cash used in operating activities		450,518
Net cash used in operating activities		(40,720)
Net cash used in investing activities		(175,000,000)
Net cash provided by financing activities		177,875,690
As Restated [Member] | Class A Common Stock [Member]
Stockholders’ equity (deficit)
Class A common stock - $0.0001 par value
Other (expense) income:
Weighted-average shares outstanding, of Class A common stock (in Shares) | shares	1,346,154	621,827
Basic and Diluted net loss per share, Class A common stock (in Dollars per share) | $ / shares	$ (0.09)	$ (0.10)
As Restated [Member] | Class B Common Stock [Member]
Stockholders’ equity (deficit)
Class B common stock - $0.0001 par value	$ 503	$ 503
As Restated [Member] | Class B Convertible Common Stock [Member]
Other (expense) income:
Weighted-average shares outstanding, of Class B convertible common stock (in Shares) | shares	4,375,000	4,375,000
Basic and Diluted net loss per share, Class B convertible common stock (in Dollars per share) | $ / shares	$ (0.09)	$ (0.10)

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements (Details) - Schedule of financial statement (Parentheticals)	Sep. 30, 2020$ / shares
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Class A common stock subject to possible redemption value	$ 10
Preferred stock, par value	0.0001
As Previously Reported [Member] | Class A Common Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock, par value	0.0001
As Previously Reported [Member] | Class B Common Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock, par value	0.0001
Restatement Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Class A common stock subject to possible redemption value	10
Preferred stock, par value	0.0001
Restatement Adjustment [Member] | Class A Common Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock, par value	0.0001
Restatement Adjustment [Member] | Class B Common Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock, par value	0.0001
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Class A common stock subject to possible redemption value	10
Preferred stock, par value	0.0001
As Restated [Member] | Class A Common Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock, par value	0.0001
As Restated [Member] | Class B Common Stock [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock, par value	$ 0.0001

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	1 Months Ended		6 Months Ended
	Sep. 24, 2020	Mar. 27, 2020	Sep. 30, 2020
Summary of Significant Accounting Policies (Textual)
Aggregate offering cost	$ 9,957,390
Underwriting fees	3,500,000
Deferred underwriting fees	6,125,000
Other offering costs	507,390
Underwriters paid	175,000
Deferred tax assets			$ 23,000
Valuation allowance			23,000
Federal depository insurance coverage limits			$ 250,000
Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Business interest limitation percentage		30.00%
Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Business interest limitation percentage		50.00%
Underwriter [Member]
Summary of Significant Accounting Policies (Textual)
Offering costs	502,848
Stockholders’ equity	$ 9,454,542
IPO [Member]
Summary of Significant Accounting Policies (Textual)
Warrants to purchase (in Shares)			14,900,000
Class A Common Stock [Member]
Summary of Significant Accounting Policies (Textual)
Common stock subject to possible redemption (in Shares)			17,500,000
Warrants’ exercise price (in Dollars per share)			$ 11.50

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of class A ordinary shares subject to possible redemption reflected on the balance sheet	6 Months Ended
	Sep. 30, 2020USD ($)
Schedule of class A ordinary shares subject to possible redemption reflected on the balance sheet [Abstract]
Gross proceeds	$ 175,000,000
Less:
Proceeds allocated to public warrants	(8,837,500)
Class A shares offering costs	(9,454,542)
Plus:
Accretion of carrying value to redemption value	18,292,042
Class A common stock subject to possible redemption	$ 175,000,000

Initial Public Offering (Detail

Initial Public Offering (Details)	6 Months Ended
	Sep. 30, 2020$ / sharesshares
Initial Public Offering (Details) [Line Items]
Sale of units | shares	17,500,000
Price per share | $ / shares	$ 10
Class A Common Stock [Member]
Initial Public Offering (Details) [Line Items]
Common stock, description	Each consists of one share of Class A common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

Private Placement (Details)

Private Placement (Details)	6 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Private Placement [Member]
Private Placement (Details) [Line Items]
Purchase of warrants (in Shares) | shares	6,150,000
Warrant price per share	$ 1
Aggregate purchase price (in Dollars) | $	$ 6,150,000
Class A Common Stock [Member]
Private Placement (Details) [Line Items]
Warrant price per share	$ 11.50

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Aug. 03, 2020	Mar. 20, 2020	Jun. 16, 2020	Sep. 30, 2020	Sep. 24, 2020
Related Party Transactions (Details) [Line Items]
Stockholders' equity note, stock split	4-for-1 forward stock split of its issued and outstanding shares of Class B common stock.
Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.				$ 10,000
Administrative fees				$ 2,000
Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Founder shares, description				The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares following the Initial Public Offering until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Promissory note			$ 150,000
Working capital loan amount				$ 1,500,000
Warrant price per share (in Dollars per share)				$ 1
Over-Allotment Option [Member]
Related Party Transactions (Details) [Line Items]
Founder shares forfeited (in Shares)				656,250
Initial Public Offering [Member]
Related Party Transactions (Details) [Line Items]
Price per share (in Dollars per share)					$ 10
Initial Public Offering [Member] | Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Related party loan				$ 150,000
Class B Convertible Common Stock [Member]
Related Party Transactions (Details) [Line Items]
Common stock, shares issued (in Shares)				5,031,250
Class B Convertible Common Stock [Member] | Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Purchase of founder common stock (in Shares)		3,593,750
Issuance of common stock for aggregate price		$ 25,000
Price per share (in Dollars per share)		$ 0.007
Founder shares outstanding (in Shares)	5,031,250
Founder shares subject to forfeiture (in Shares)	656,250
Issued and outstanding shares percentage	20.00%
Redeem public shares percentage				100.00%

Commitments and Contingencies (

Commitments and Contingencies (Details)	6 Months Ended
	Sep. 30, 2020USD ($)$ / shares
Commitments and Contingencies Disclosure [Abstract]
Deferred fee per unit price | $ / shares	$ 0.35
Deferred underwriters fee | $	$ 6,125,000

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Details)	6 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred stock, shares authorized	1,000,000
Preferred stock par value (in Dollars per share) | $ / shares	$ 0.0001
Shares outstanding percentage of initial public offering	20.00%
Warrant expire period	5 years
Warrants for redemption, description	Once the warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption; ● if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.
Effective issue price (in Dollars per share) | $ / shares	$ 9.20
Equity interest percentage	50.00%
Market value issuance percentage (in Dollars per share) | $ / shares	$ 9.20
Fair market value percentage	115.00%
Warrant price per share (in Dollars per share) | $ / shares	$ 18
Market value issuance	180.00%
Class A Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock, shares authorized	75,000,000
Common stock, shares issued	17,500,000
Common stock, shares outstanding	17,500,000
Common stock subject to possible redemption	17,500,000
Class B Convertible Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock, shares authorized	10,000,000
Common stock, shares issued	5,031,250
Over-allotment option shares forfeiture (in Dollars) | $	$ 656,250

Fair Value Measurements (Detail

Fair Value Measurements (Details)	6 Months Ended
	Sep. 30, 2020USD ($)
Fair Value Disclosures [Abstract]
Assets held in the Trust Account	$ 579
Cash in U.S.Treasury Bills	$ 175,001,847

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of fair value of held-to-maturity securities - U.S. Treasury Securities [Member]	6 Months Ended
	Sep. 30, 2020USD ($)
Fair Value Measurements (Details) - Schedule of fair value of held-to-maturity securities [Line Items]
Level 1: Held-To-Maturity	U.S. Treasury Securities (Mature on 03/25/2021)
Amortized Cost	$ 175,001,847
Gross Holding Losses	(17,628)
Fair Value	$ 174,984,219

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis	Sep. 30, 2020USD ($)
Assets:
Cash and marketable securities held in Trust Account	$ 175,002,426
Liabilities:
Warrant Liability – Public Warrants	8,837,500
Warrant Liability – Private Placement Warrants	6,027,000
Quoted Prices in Active Markets (Level 1) [Member]
Assets:
Cash and marketable securities held in Trust Account	175,002,426
Liabilities:
Warrant Liability – Public Warrants
Warrant Liability – Private Placement Warrants
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Cash and marketable securities held in Trust Account
Liabilities:
Warrant Liability – Public Warrants
Warrant Liability – Private Placement Warrants
Significant Other Unobservable Inputs (Level 3) [Member]
Assets:
Cash and marketable securities held in Trust Account
Liabilities:
Warrant Liability – Public Warrants	8,837,500
Warrant Liability – Private Placement Warrants	$ 6,027,000

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of quantitative information regarding level 3 fair value measurements	6 Months Ended
	Sep. 30, 2020$ / shares
Schedule of quantitative information regarding level 3 fair value measurements [Abstract]
Stock price (in Dollars per share)	$ 9.50
Strike price (in Dollars per share)	$ 11.50
Term (in years)	5 years
Volatility	25.00%
Risk-free rate	0.41%
Dividend yield	0.00%
Probability of completing a Business Combination	70.00%

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities	6 Months Ended
	Sep. 30, 2020USD ($)
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Fair value beginning balance
Initial measurement on September 30, 2020	14,864,500	[1]
Change in fair value recognized in earnings
Fair value ending balance	14,864,500
Private Warrants [Member]
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Fair value beginning balance
Initial measurement on September 30, 2020	6,027,000	[1]
Change in fair value recognized in earnings
Fair value ending balance	6,027,000
Public Warrants [Member]
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Fair value beginning balance
Initial measurement on September 30, 2020	8,837,500	[1]
Change in fair value recognized in earnings
Fair value ending balance	$ 8,837,500
[1]	There was no measurable difference in fair value between the date of our Initial Public Offering on September 24, 2020, and September 30, 2020.